Zimmer Biomet Holdings (ZBH) Misses Q4 EPS by 3c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Zimmer Biomet (ZBH) PT Lowered to $128 at Truist Securities
February 8, 2022 6:38 AM ESTTruist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $128.00 (from $145.00) while maintaining a Buy rating following results.
The analyst commented, "We remain Buy rated following a noisy 4Q/'22 guide, which disappointed on a more sanguine COVID... More
